620
Views
15
CrossRef citations to date
0
Altmetric
Invited Review

Optical and pharmacological strategies of myopia control

, PhD BOptom (Hons) FAAO
Pages 321-332 | Received 06 Jul 2017, Accepted 04 Jan 2018, Published online: 15 Apr 2021

REFERENCES

  • Flitcroft DI. Is myopia a failure of homeostasis? Exp Eye Res 2013; 114: 16–24.
  • Wallman J, Winawer J. Homeostasis of eye growth and the question of myopia. Neuron 2004; 43: 447–468.
  • Xie R, Zhou XT, Lu F et al. Correlation between myopia and major biometric parameters of the eye: a retrospective clinical study. Optom Vis Sci 2009; 86: E503–E508.
  • Mcbrien NA, Adams DW. A longitudinal investigation of adult‐onset and adult‐progression of myopia in an occupational group. Refractive and biometric findings. Invest Ophthalmol Vis Sci 1997; 38: 321–333.
  • Kinge B, Midelfart A, Jacobsen G et al. Biometric changes in the eyes of Norwegian university students‐‐a three‐year longitudinal study. Acta Ophthalmol Scand 1999; 77: 648–652.
  • Saw SM, Chua WH, Gazzard G et al. Eye growth changes in myopic children in Singapore. Br J Ophthalmol 2005; 89: 1489–1494.
  • Fan DS, Cheung EY, Lai RY et al. Myopia progression among preschool Chinese children in Hong Kong. Ann Acad Med Singapore 2004; 33: 39–43.
  • Saw SM. How blinding is pathological myopia? Br J Ophthalmol 2006; 90: 525–526.
  • Saw SM, Gazzard G, Shih‐yen EC et al. Myopia and associated pathological complications. Ophthalmic Physiol Opt 2005; 25: 381–391.
  • Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res 2012; 31: 622–660.
  • Morgan IG, Ohno‐matsui K, Saw SM. Myopia. Lancet 2012; 379: 1739–1748.
  • World Health Organization. The impact of myopia and high myopia: report of the Joint World Health Organization–Brien Holden Vision Institute Global Scientific Meeting on Myopia, University of New South Wales, Sydney, Australia, 16–18 March 2015. Geneva: World Health Organization; 2017. Licence: CC BY‐NC‐SA 3.0 IGO
  • Verkicharla PK, Ohno‐matsui K, Saw SM. Current and predicted demographics of high myopia and an update of its associated pathological changes. Ophthalmic Physiol Opt 2015; 35: 465–475.
  • Lin LL, Shih YF, Hsiao CK et al. Prevalence of myopia in Taiwanese schoolchildren: 1983 to 2000. Ann Acad Med Singapore 2004; 33: 27–33.
  • Lam CS, Goh WS, Tang YK et al. Changes in refractive trends and optical components of Hong Kong Chinese aged over 40 years. Ophthalmic Physiol Opt 1994; 14: 383–388.
  • Vitale S, Sperduto RD, Ferris FL 3rd. Increased prevalence of myopia in the United States between 1971‐1972 and 1999‐2004. Arch Ophthalmol 2009; 127: 1632–1639.
  • Williams KM, Bertelsen G, Cumberland P et al. Increasing prevalence of myopia in Europe and the impact of education. Ophthalmology 2015; 122: 1489–1497.
  • Koh V, Yang A, Saw SM et al. Differences in prevalence of refractive errors in young Asian males in Singapore between 1996‐1997 and 2009‐2010. Ophthalmic Epidemiol 2014; 21: 247–255.
  • Dolgin E. The myopia boom. Nature 2015; 519: 276–278.
  • Sun J, Zhou J, Zhao P et al. High prevalence of myopia and high myopia in 5060 Chinese university students in Shanghai. Invest Ophthalmol Vis Sci 2012; 53: 7504–7509.
  • Jung SK, Lee JH, Kakizaki H et al. Prevalence of myopia and its association with body stature and educational level in 19‐year‐old male conscripts in Seoul, South Korea. Invest Ophthalmol Vis Sci 2012; 53: 5579–5583.
  • Holden BA, Fricke TR, Wilson DA et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology 2016; 123: 1036–1042.
  • Smith EL III. Optical treatment strategies to slow myopia progression: effects of the visual extent of the optical treatment zone. Exp Eye Res 2013; 114: 77–88.
  • Gifford P, Gifford KL. The future of myopia control contact lenses. Optom Vis Sci 2016; 93: 336–343.
  • Smith EL III. Prentice award lecture 2010: a case for peripheral optical treatment strategies for myopia. Optom Vis Sci 2011; 88: 1029–1044.
  • Sankaridurg P. Contact lenses to slow progression of myopia. Clin Exp Optom 2017; 100: 432–437.
  • Li SM, Kang MT, Wu SS et al. Studies using concentric ring bifocal and peripheral add multifocal contact lenses to slow myopia progression in school‐aged children: a meta‐analysis. Ophthalmic Physiol Opt 2017; 37: 51–59.
  • Katz J, Schein OD, Levy B et al. A randomized trial of rigid gas permeable contact lenses to reduce progression of children's myopia. Am J Ophthalmol 2003; 136: 82–90.
  • Walline JJ, Jones LA, Mutti DO et al. A randomized trial of the effects of rigid contact lenses on myopia progression. Arch Ophthalmol 2004; 122: 1760–1766.
  • Walline JJ, Lindsley K, Vedula SS et al. Interventions to slow progression of myopia in children. Cochrane Database Syst Rev 2011: CD004916.
  • Vasudevan B, Esposito C, Peterson C et al. Under‐correction of human myopia‐is it myopigenic?: a retrospective analysis of clinical refraction data. J Optom 2014; 7: 147–152.
  • Chung K, Mohidin N, O'leary DJ. Undercorrection of myopia enhances rather than inhibits myopia progression. Vision Res 2002; 42: 2555–2559.
  • Adler D, Millodot M. The possible effect of undercorrection on myopic progression in children. Clin Exp Optom 2006; 89: 315–321.
  • Sun YY, Li SM, Li SY et al. Effect of uncorrection versus full correction on myopia progression in 12‐year‐old children. Graefes Arch Clin Exp Ophthalmol 2017; 255: 189–195.
  • Cheng D, Woo GC, Schmid KL. Bifocal lens control of myopic progression in children. Clin Exp Optom 2011; 94: 24–32.
  • Gwiazda J, Hyman L, Hussein M et al. A randomized clinical trial of progressive addition lenses versus single vision lenses on the progression of myopia in children. Invest Ophthalmol Vis Sci 2003; 44: 1492–1500.
  • Correction of Myopia Evaluation Trial 2 Study Group for the Pediatric Eye Disease Investigator Group. Progressive‐addition lenses versus single‐vision lenses for slowing progression of myopia in children with high accommodative lag and near esophoria. Invest Ophthalmol Vis Sci 2011; 52: 2749–2757.
  • Berntsen DA, Sinnott LT, Mutti DO et al. A randomized trial using progressive addition lenses to evaluate theories of myopia progression in children with a high lag of accommodation. Invest Ophthalmol Vis Sci 2012; 53: 640–649.
  • Cheng D, Schmid KL, Woo GC. The effect of positive‐lens addition and base‐in prism on accommodation accuracy and near horizontal phoria in Chinese myopic children. Ophthalmic Physiol Opt 2008; 28: 225–237.
  • Gwiazda J, Thorn F, Bauer J et al. Myopic children show insufficient accommodative response to blur. Invest Ophthalmol Vis Sci 1993; 34: 690–694.
  • Gwiazda J, Bauer J, Thorn F et al. A dynamic relationship between myopia and blur‐driven accommodation in school‐aged children. Vision Res 1995; 35: 1299–1304.
  • Gwiazda J, Thorn F, Held R. Accommodation, accommodative convergence, and response AC/A ratios before and at the onset of myopia in children. Optom Vis Sci 2005; 82: 273–278.
  • Mutti DO, Mitchell GL, Hayes JR et al. Accommodative lag before and after the onset of myopia. Invest Ophthalmol Vis Sci 2006; 47: 837–846.
  • Berntsen DA, Sinnott LT, Mutti DO et al. Accommodative lag and juvenile‐onset myopia progression in children wearing refractive correction. Vision Res 2011; 51: 1039–1046.
  • Koomson NY, Amedo AO, Opoku‐baah C et al. Relationship between reduced accommodative lag and myopia progression. Optom Vis Sci 2016; 93: 683–691.
  • Gwiazda JE, Hyman L, Norton TT et al. Accommodation and related risk factors associated with myopia progression and their interaction with treatment in COMET children. Invest Ophthalmol Vis Sci 2004; 45: 2143–2151.
  • Saw SM, Chua WH, Hong CY et al. Nearwork in early‐onset myopia. Invest Ophthalmol Vis Sci 2002; 43: 332–339.
  • French AN, Morgan IG, Mitchell P et al. Risk factors for incident myopia in Australian schoolchildren: the Sydney adolescent vascular and eye study. Ophthalmology 2013; 120: 2100–2108.
  • Mutti DO, Mitchell GL, Moeschberger ML et al. Parental myopia, near work, school achievement, and children's refractive error. Invest Ophthalmol Vis Sci 2002; 43: 3633–3640.
  • Ip JM, Saw SM, Rose KA et al. Role of near work in myopia: findings in a sample of Australian school children. Invest Ophthalmol Vis Sci 2008; 49: 2903–2910.
  • Hasebe S, Ohtsuki H, Nonaka T et al. Effect of progressive addition lenses on myopia progression in Japanese children: a prospective, randomized, double‐masked, crossover trial. Invest Ophthalmol Vis Sci 2008; 49: 2781–2789.
  • Yang Z, Lan W, Ge J et al. The effectiveness of progressive addition lenses on the progression of myopia in Chinese children. Ophthalmic Physiol Opt 2009; 29: 41–48.
  • Fulk GW, Cyert LA, Parker DE. A randomized trial of the effect of single‐vision vs. bifocal lenses on myopia progression in children with esophoria. Optom Vis Sci 2000; 77: 395–401.
  • Pärssinen O, Hemminki E, Klemetti A. Effect of spectacle use and accommodation on myopic progression: final results of a three‐year randomised clinical trial among schoolchildren. Br J Ophthalmol 1989; 73: 547–551.
  • Fulk GW, Cyert LA. Can bifocals slow myopia progression? J Am Optom Assoc 1996; 67: 749–754.
  • Grosvenor T, Perrigin DM, Perrigin J et al. Houston Myopia Control Study: a randomized clinical trial. Part II. Final report by the patient care team. Am J Optom Physiol Opt 1987; 64: 482–498.
  • Cheng D, Woo GC, Drobe B et al. Effect of bifocal and prismatic bifocal spectacles on myopia progression in children: three‐year results of a randomized clinical trial. JAMA Ophthalmol 2014; 132: 258–264.
  • Schilling T, Ohlendorf A, Varnas SR et al. Peripheral design of progressive addition lenses and the lag of accommodation in myopes. Invest Ophthalmol Vis Sci 2017; 58: 3319–3324.
  • Smith EL III, Kee CS, Ramamirtham R et al. Peripheral vision can influence eye growth and refractive development in infant monkeys. Invest Ophthalmol Vis Sci 2005; 46: 3965–3972.
  • Smith EL III, Ramamirtham R, Qiao‐grider Y et al. Effects of foveal ablation on emmetropization and form‐deprivation myopia. Invest Ophthalmol Vis Sci 2007; 48: 3914–3922.
  • Smith EL III, Hung LF, Huang J. Relative peripheral hyperopic defocus alters central refractive development in infant monkeys. Vision Res 2009; 49: 2386–2392.
  • Benavente‐perez A, Nour A, Troilo D. Axial eye growth and refractive error development can be modified by exposing the peripheral retina to relative myopic or hyperopic defocus. Invest Ophthalmol Vis Sci 2014; 55: 6765–6773.
  • Liu Y, Wildsoet C. The effect of two‐zone concentric bifocal spectacle lenses on refractive error development and eye growth in young chicks. Invest Ophthalmol Vis Sci 2011; 52: 1078–1086.
  • Liu Y, Wildsoet C. The effective add inherent in 2‐zone negative lenses inhibits eye growth in myopic young chicks. Invest Ophthalmol Vis Sci 2012; 53: 5085–5093.
  • Tepelus TC, Vazquez D, Seidemann A et al. Effects of lenses with different power profiles on eye shape in chickens. Vision Res 2012; 54: 12–19.
  • Charman WN, Radhakrishnan H. Peripheral refraction and the development of refractive error: a review. Ophthalmic Physiol Opt 2010; 30: 321–338.
  • Sankaridurg P, Donovan L, Varnas S et al. Spectacle lenses designed to reduce progression of myopia: 12‐month results. Optom Vis Sci 2010; 87: 631–641.
  • Tabernero J, Vazquez D, Seidemann A et al. Effects of myopic spectacle correction and radial refractive gradient spectacles on peripheral refraction. Vision Res 2009; 49: 2176–2186.
  • Sankaridurg P, Holden B, Smith E 3rd et al. Decrease in rate of myopia progression with a contact lens designed to reduce relative peripheral hyperopia: one‐year results. Invest Ophthalmol Vis Sci 2011; 52: 9362–9367.
  • Paune J, Queiros A, Lopes‐ferreira D et al. Efficacy of a gas permeable contact lens to induce peripheral myopic defocus. Optom Vis Sci 2015; 92: 596–603.
  • Lam CS, Tang WC, Tse DY et al. Defocus Incorporated Soft Contact (DISC) lens slows myopia progression in Hong Kong Chinese schoolchildren: a 2‐year randomised clinical trial. Br J Ophthalmol 2014; 98: 40–45.
  • Paune J, Morales H, Armengol J et al. Myopia control with a novel peripheral gradient soft lens and orthokeratology: a 2‐year clinical trial. Biomed Res Int 2015; 2015: 507572.
  • Cheng X, Xu J, Chehab K et al. Soft contact lenses with positive spherical aberration for myopia control. Optom Vis Sci 2016; 93: 353–366.
  • Paune J, Queiros A, Quevedo L et al. Peripheral myopization and visual performance with experimental rigid gas permeable and soft contact lens design. Cont Lens Anterior Eye 2014; 37: 455–460.
  • Anstice NS, Phillips JR. Effect of dual‐focus soft contact lens wear on axial myopia progression in children. Ophthalmology 2011; 118: 1152–1161.
  • Fujikado T, Ninomiya S, Kobayashi T et al. Effect of low‐addition soft contact lenses with decentered optical design on myopia progression in children: a pilot study. Clin Ophthalmol 2014; 8: 1947–1956.
  • Kang P, Fan Y, Oh K et al. The effect of multifocal soft contact lenses on peripheral refraction. Optom Vis Sci 2013; 90: 658–666.
  • Berntsen DA, Kramer CE. Peripheral defocus with spherical and multifocal soft contact lenses. Optom Vis Sci 2013; 90: 1215–1224.
  • Lopes‐ferreira D, Ribeiro C, Maia R et al. Peripheral myopization using a dominant design multifocal contact lens. J Optom 2011; 4: 14–21.
  • Walline JJ, Greiner KL, Mcvey ME et al. Multifocal contact lens myopia control. Optom Vis Sci 2013; 90: 1207–1214.
  • Aller TA, Liu M, Wildsoet CF. Myopia control with bifocal contact lenses: a randomized clinical trial. Optom Vis Sci 2016; 93: 344–352.
  • Swarbrick HA. Orthokeratology review and update. Clin Exp Optom 2006; 89: 124–143.
  • Swarbrick HA, Alharbi A, Watt K et al. Myopia control during orthokeratology lens wear in children using a novel study design. Ophthalmology 2015; 122: 620–630.
  • Santodomingo‐rubido J, Villa‐collar C, Gilmartin B et al. Myopia control with orthokeratology contact lenses in Spain: refractive and biometric changes. Invest Ophthalmol Vis Sci 2012; 53: 5060–5065.
  • Kakita T, Hiraoka T, Oshika T. Influence of overnight orthokeratology on axial elongation in childhood myopia. Invest Ophthalmol Vis Sci 2011; 52: 2170–2174.
  • Cho P, Cheung SW. Retardation of myopia in Orthokeratology (ROMIO) study: a 2‐year randomized clinical trial. Invest Ophthalmol Vis Sci 2012; 53: 7077–7085.
  • Cho P, Cheung SW, Edwards M. The longitudinal orthokeratology research in children (LORIC) in Hong Kong: a pilot study on refractive changes and myopic control. Curr Eye Res 2005; 30: 71–80.
  • Huang J, Wen D, Wang Q et al. Efficacy comparison of 16 interventions for myopia control in children: a network meta‐analysis. Ophthalmology 2016; 123: 697–708.
  • Kang P, Swarbrick H. New perspective on myopia control with orthokeratology. Optom Vis Sci 2016; 93: 497–503.
  • Kang P, Swarbrick H. Peripheral refraction in myopic children wearing orthokeratology and gas‐permeable lenses. Optom Vis Sci 2011; 88: 476–482.
  • Kang P, Swarbrick H. Time course of the effects of orthokeratology on peripheral refraction and corneal topography. Ophthalmic Physiol Opt 2013; 33: 277–282.
  • Cho P, Cheung SW, Edwards MH. Practice of orthokeratology by a group of contact lens practitioners in Hong Kong‐‐Part 1. General overview. Clin Exp Optom 2002; 85: 365–371.
  • Cho P, Cheung SW, Edwards MH et al. An assessment of consecutively presenting orthokeratology patients in a Hong Kong based private practice. Clin Exp Optom 2003; 86: 331–338.
  • Walline JJ, Jones LA, Sinnott LT. Corneal reshaping and myopia progression. Br J Ophthalmol 2009; 93: 1181–1185.
  • Sun Y, Xu F, Zhang T et al. Orthokeratology to control myopia progression: a meta‐analysis. PLoS One 2015; 10: e0124535.
  • Si JK, Tang K, Bi HS et al. Orthokeratology for myopia control: a meta‐analysis. Optom Vis Sci 2015; 92: 252–257.
  • Chen C, Cheung SW, Cho P. Myopia control using toric orthokeratology (TO‐SEE study). Invest Ophthalmol Vis Sci 2013; 54: 6510–6517.
  • Charm J, Cho P. High myopia‐partial reduction ortho‐k: a 2‐year randomized study. Optom Vis Sci 2013; 90: 530–539.
  • Hiraoka T, Kakita T, Okamoto F et al. Long‐term effect of overnight orthokeratology on axial length elongation in childhood myopia: a 5‐year follow‐up study. Invest Ophthalmol Vis Sci 2012; 53: 3913–3919.
  • Downie LE, Lowe R. Corneal reshaping influences myopic prescription stability (CRIMPS): an analysis of the effect of orthokeratology on childhood myopic refractive stability. Eye Contact Lens 2013; 39: 303–310.
  • Cho P, Cheung SW. Discontinuation of orthokeratology on eyeball elongation (DOEE). Cont Lens Anterior Eye 2017; 40: 82–87.
  • Sng CC, Lin XY, Gazzard G et al. Change in peripheral refraction over time in Singapore Chinese children. Invest Ophthalmol Vis Sci 2011; 52: 7880–7887.
  • Mutti DO, Sinnott LT, Mitchell GL et al. Relative peripheral refractive error and the risk of onset and progression of myopia in children. Invest Ophthalmol Vis Sci 2011; 52: 199–205.
  • Atchison DA, Li SM, Li H et al. Relative peripheral hyperopia does not predict development and progression of myopia in children. Invest Ophthalmol Vis Sci 2015; 56: 6162–6170.
  • Lee TT, Cho P. Relative peripheral refraction in children: twelve‐month changes in eyes with different ametropias. Ophthalmic Physiol Opt 2013; 33: 283–293.
  • Tarrant J, Liu Y, Wildsoet CF. Orthokeratology can decrease accommodative lag in myopes. Invest Ophthalmol Vis Sci 2009; 50: E‐Abstract 4294.
  • Brand P. The effect of orthokeratology on accommodative and convergence function: a clinic based pilot study. Optom Vis Perform 2013; 1: 162–167.
  • Gifford K, Gifford P, Hendicott PL et al. Near binocular visual function in young adult orthokeratology versus soft contact lens wearers. Cont Lens Anterior Eye 2017; 40: 184–189.
  • Bedrossian RH. The effect of atropine on myopia. Ann Ophthalmol 1971; 3: 891–897.
  • Bedrossian RH. The effect of atropine on myopia. Ophthalmology 1979; 86: 713–719.
  • Kelly TS, Chatfield C, Tustin G. Clinical assessment of the arrest of myopia. Br J Ophthalmol 1975; 59: 529–538.
  • Gimbel HV. The control of myopia with atropine. Can J Ophthalmol 1973; 8: 527–532.
  • Ganesan P, Wildsoet CF. Pharmaceutical intervention for myopia control. Expert Rev Ophthalmol 2010; 5: 759–787.
  • Pineles SL, Kraker RT, Vanderveen DK et al. Atropine for the prevention of myopia progression in children: a report by the American Academy of Ophthalmology. Ophthalmology 2017; 124: 1857–1866.
  • Schaeffel F, Troilo D, Wallman J et al. Developing eyes that lack accommodation grow to compensate for imposed defocus. Vis Neurosci 1990; 4: 177–183.
  • Wildsoet CF, Howland HC, Falconer S et al. Chromatic aberration and accommodation: their role in emmetropization in the chick. Vision Res 1993; 33: 1593–1603.
  • Schwahn HN, Schaeffel F. Chick eyes under cycloplegia compensate for spectacle lenses despite six‐hydroxy dopamine treatment. Invest Ophthalmol Vis Sci 1994; 35: 3516–3524.
  • Mcbrien NA, Moghaddam HO, Reeder AP. Atropine reduces experimental myopia and eye enlargement via a nonaccommodative mechanism. Invest Ophthalmol Vis Sci 1993; 34: 205–215.
  • Liu S, Li J, Tan DT et al. Expression and function of muscarinic receptor subtypes on human cornea and conjunctiva. Invest Ophthalmol Vis Sci 2007; 48: 2987–2996.
  • Collison DJ, Coleman RA, James RS et al. Characterization of muscarinic receptors in human lens cells by pharmacologic and molecular techniques. Invest Ophthalmol Vis Sci 2000; 41: 2633–2641.
  • Qu J, Zhou X, Xie R et al. The presence of m1 to m5 receptors in human sclera: evidence of the sclera as a potential site of action for muscarinic receptor antagonists. Curr Eye Res 2006; 31: 587–597.
  • Fang YT, Chou YJ, Pu C et al. Prescription of atropine eye drops among children diagnosed with myopia in Taiwan from 2000 to 2007: a nationwide study. Eye (Lond) 2013; 27: 418–424.
  • Chua WH, Balakrishnan V, Chan YH et al. Atropine for the treatment of childhood myopia. Ophthalmology 2006; 113: 2285–2291.
  • Song YY, Wang H, Wang BS et al. Atropine in ameliorating the progression of myopia in children with mild to moderate myopia: a meta‐analysis of controlled clinical trials. J Ocul Pharmacol Ther 2011; 27: 361–368.
  • Chia A, Chua WH, Cheung YB et al. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5 per cent, 0.1 per cent, and 0.01 per cent doses (Atropine for the Treatment of Myopia 2). Ophthalmology 2012; 119: 347–354.
  • Shih YF, Chen CH, Chou AC et al. Effects of different concentrations of atropine on controlling myopia in myopic children. J Ocul Pharmacol Ther 1999; 15: 85–90.
  • Clark TY, Clark RA. Atropine 0.01 per cent eyedrops significantly reduce the progression of childhood myopia. J Ocul Pharmacol Ther 2015; 31: 541–545.
  • Chia A, Chua WH, Wen L et al. Atropine for the treatment of childhood myopia: changes after stopping atropine 0.01%, 0.1% and 0.5%. Am J Ophthalmol 2014; 157: 451–457.e1.
  • Tong L, Huang XL, Koh AL et al. Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine. Ophthalmology 2009; 116: 572–579.
  • Chia A, Lu QS, Tan D. Five‐year clinical trial on atropine for the treatment of myopia 2: myopia control with atropine 0.01 per cent eyedrops. Ophthalmology 2016; 123: 391–399.
  • Cooper J, Eisenberg N, Schulman E et al. Maximum atropine dose without clinical signs or symptoms. Optom Vis Sci 2013; 90: 1467–1472.
  • Loughman J, Flitcroft D. The acceptability and visual impact of 0.01 per cent atropine in a Caucasian population. Br J Ophthalmol 2016; 100: 1525–1529.
  • Cottriall CL, Mcbrien NA. The M1 muscarinic antagonist pirenzepine reduces myopia and eye enlargement in the tree shrew. Invest Ophthalmol Vis Sci 1996; 37: 1368–1379.
  • Leech EM, Cottriall CL, Mcbrien NA. Pirenzepine prevents form deprivation myopia in a dose dependent manner. Ophthalmic Physiol Opt 1995; 15: 351–356.
  • Tan DT, Lam DS, Chua WH et al. One‐year multicenter, double‐masked, placebo‐controlled, parallel safety and efficacy study of 2 per cent pirenzepine ophthalmic gel in children with myopia. Ophthalmology 2005; 112: 84–91.
  • Siatkowski RM, Cotter SA, Crockett RS et al. Two‐year multicenter, randomized, double‐masked, placebo‐controlled, parallel safety and efficacy study of 2 per cent pirenzepine ophthalmic gel in children with myopia. J AAPOS 2008; 12: 332–339.
  • Siatkowski RM, Cotter S, Miller JM et al. Safety and efficacy of 2 per cent pirenzepine ophthalmic gel in children with myopia: a 1‐year, multicenter, double‐masked, placebo‐controlled parallel study. Arch Ophthalmol 2004; 122: 1667–1674.
  • Kang P, Gifford P, Swarbrick H. Can manipulation of orthokeratology lens parameters modify peripheral refraction? Optom Vis Sci 2013; 90: 1237–1248.
  • Li SM, Wu SS, Kang MT et al. Atropine slows myopia progression more in Asian than white children by meta‐analysis. Optom Vis Sci 2014; 91: 342–350.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.